Marker Therapeutics

+$0.11 (+3.40%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell MRKR and other stocks, options, and ETFs commission-free!

About MRKR

Marker Therapeutics, Inc. Common Stock, also called Marker Therapeutics, is a clinical-stage immuno-oncology company, which engages in the development and commercialization of novel cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications.

CEO
Peter L. Hoang
Employees
44
Headquarters
Houston, Texas
Founded
1991

MRKR Key Statistics

Market Cap
278.10M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.21M
High Today
$3.39
Low Today
$3.23
Open Price
$3.25
Volume
824.99K
52 Week High
$3.77
52 Week Low
$1.32

MRKR Earnings

-$0.18
-$0.12
-$0.06
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 9, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure